Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial.

@article{Cohen2003ContinuousSI,
  title={Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial.},
  author={Daniela M Cohen and Naomi Weintrob and Hadassa Benzaquen and Avinoam Galatzer and Gila Fayman and Moshe Phillip},
  journal={Journal of pediatric endocrinology & metabolism : JPEM},
  year={2003},
  volume={16 7},
  pages={
          1047-50
        }
}
Intensive therapy for type 1 diabetes mellitus (DM) is usually provided by either multiple daily injections of insulin (MDI) or by insulin pump (continuous subcutaneous insulin infusion CSII). We designed an open, randomized, crossover trial to compare CSII with MDI for glycemic control, dose requirements, weight change, incidence of adverse events, quality of life and satisfaction in adolescents. 

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS